schumideena

Long on GILD

Long
schumideena Updated   
NASDAQ:GILD   Gilead Sciences, Inc.
Gild after reaching 52 week low is also in oversold territory. After the acquisition news, still it has not moved up. Would be a good buy opportunity for long term. Short term targets are marked in the charts
Trade active
Trade closed: target reached
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.